2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1053517789 M.D
Verify on CMS →

ANJALI PAREKH, M.D

Glaucoma Specialist (Ophthalmology) Physician in SAN DIEGO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 459 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
73.6207/100
▼ 9 pts below national avg 83.1 · [object Object]
What the federal data reveals: ANJALI PAREKH, M.D is a Glaucoma Specialist (Ophthalmology) Physician ([object Object]) practicing in SAN DIEGO, California with a Medicare Part D prescribing footprint of 2K claims across 459 beneficiaries — 45% brand-name prescribing . Their CMS MIPS Final Score of 73.6207/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What the federal data shows

ANJALI PAREKH, M.D reported a CMS MIPS final score of 73.6207/100 — below the 83.1 national average — and filed 1,971 Medicare Part D claims in 2023.

73.6207/100
MIPS score · -9 vs avg
2K
Part D claims, 2023
55%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANJALI PAREKH, M.D's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

74 11th percentile higher than 11% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ANJALI PAREKH, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ANJALI PAREKH, M.D at a glance

Below national average

NPI registry status

Active

Issued 06/21/2007

NPI 1053517789

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

1,971 33% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

73.6207/100 9.479299999999995% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in California

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among California providers

California providers

Glaucoma Specialist (Ophthalmology) Physician share within California

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within California

Medicare quality performance — MIPS

ANJALI PAREKH, M.D's 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

Below national average
MIPS Final Score
73.6207/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 73.6207/100 vs national avg 83.1

0%100%National avg83%73.6%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 73.6207/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANJALI PAREKH, M.D is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in SAN DIEGO, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D. NPI: 1053517789. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ANJALI PAREKH, M.D appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding M.D credentials at 16899 W BERNARDO DR, SAN DIEGO, CA, 92127, with a listed phone of (858) 521-2301. NPI 1053517789 was issued on 06/21/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PAREKH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,971 prescription claims written by this provider, covering 459 Medicare beneficiaries and totaling roughly $324K in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.6207/100 for the 2023 performance year (Quality 74.5653, Cost 58.6993), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

16899 W BERNARDO DR
SAN DIEGO, CA 92127

Provider Details

NPI 1053517789
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials M.D
Gender Female
NPI Issued 06/21/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

73.6207
Final Score
Avg: 83.1
74.5653
Quality
58.6993
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where ANJALI PAREKH, M.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SHARP REES-STEALY MEDICAL GROUP INC
SAN DIEGO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ANJALI PAREKH, M.D. To verify ANJALI PAREKH, M.D's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ANJALI PAREKH, M.D — brand share 45.0%
Specialty average (est.)

45% brand-name claims vs 55% generic, on 1,971 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,971
Total Claims
$324K
Total Drug Cost
459
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,134
Total Day Supply
120,225
Brand vs Generic
45% brand / 55% generic
Brand Drug Cost
$254K
Generic Drug Cost
$70K

Patient Demographics

Average Patient Age
77.1 years
Avg HCC Risk Score
1.13
Gender Split
56% female / 44% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
827
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
302
Dorzolamide Hcl
129
Prednisolone Acetate
129
Lumigan
Bimatoprost
109
Timolol Maleate
50
Erythromycin
Erythromycin Base
43
Restasis
Cyclosporine
43
Travoprost
37
Xiidra
Lifitegrast
37

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How ANJALI PAREKH, M.D fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

ANJALI PAREKH, M.D's 1,971 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as PAREKH.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANJALI PAREKH, M.D's specialty?
ANJALI PAREKH, M.D specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in SAN DIEGO, California. Credentials: M.D.
How much does ANJALI PAREKH, M.D prescribe under Medicare Part D?
In 2023, ANJALI PAREKH, M.D wrote 1,971 Medicare Part D claims totaling $324K in drug costs for 459 beneficiaries.
What is ANJALI PAREKH, M.D's Medicare quality score?
ANJALI PAREKH, M.D has a CMS MIPS Final Score of 73.6207/100 (Quality: 74.5653, Cost: 58.6993). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ANJALI PAREKH, M.D located?
ANJALI PAREKH, M.D is located at 16899 W BERNARDO DR, SAN DIEGO, CA, 92127. Phone: (858) 521-2301.
What is ANJALI PAREKH, M.D's NPI number?
ANJALI PAREKH, M.D's National Provider Identifier (NPI) is 1053517789, issued on 06/21/2007.
Does ANJALI PAREKH, M.D prescribe more brand-name or generic drugs?
ANJALI PAREKH, M.D's prescribing is 45% brand-name and 55% generic drugs by claim count, with $254K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does ANJALI PAREKH, M.D prescribe most often?
Based on 2023 Medicare Part D data, ANJALI PAREKH, M.D's most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Dorzolamide Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANJALI PAREKH, M.D accept Medicare?
ANJALI PAREKH, M.D appears in CMS Medicare data with 1,971 Part D claims and 459 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANJALI PAREKH, M.D's credentials?
ANJALI PAREKH, M.D's NPI is 1053517789 with credentials M.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology